Susquehanna International Group’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48K | Buy |
+45,320
| New | +$48K | ﹤0.01% | 6038 |
|
|
2024
Q3 | – | Sell |
-31,245
| Closed | -$67.2K | – | 5605 |
|
|
2024
Q2 | $67.2K | Sell |
31,245
-171,605
| -85% | -$369K | ﹤0.01% | 5211 |
|
|
2024
Q1 | $659K | Buy |
202,850
+103,446
| +104% | +$336K | ﹤0.01% | 3160 |
|
|
2023
Q4 | $2.04M | Buy |
99,404
+75,141
| +310% | +$1.54M | ﹤0.01% | 1925 |
|
|
2023
Q3 | $390K | Buy |
+24,263
| New | +$390K | ﹤0.01% | 3743 |
|
|
2022
Q4 | – | Sell |
-16,827
| Closed | -$292K | – | 5802 |
|
|
2022
Q3 | $292K | Sell |
16,827
-10,192
| -38% | -$177K | ﹤0.01% | 4256 |
|
|
2022
Q2 | $209K | Buy |
+27,019
| New | +$209K | ﹤0.01% | 4499 |
|